NCT03416205

Brief Summary

Endoscopic retrograde cholangiopancreatography (ERCP) is commonly performed to remove bile duct stones.Endoscopic sphincterotomy (EST), endoscopic papillary balloon dilation (EPBD), and endoscopic sphincterotomy plus balloon dilation (sEST+EPBD) are 3 methods used to enlarge the papillary orifice, but their efficacy and safety remains controversial. This study aimed to compare these methods for treating common bile duct (CBD) stones.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
450

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

July 20, 2017

Completed
7 months until next milestone

First Posted

Study publicly available on registry

January 31, 2018

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2021

Completed
Last Updated

March 19, 2018

Status Verified

May 1, 2017

Enrollment Period

4.1 years

First QC Date

May 15, 2017

Last Update Submit

March 15, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • the incidence of composite events of infection, hemorrhage, perforation, pancreatitis

    Investigators comprehensively assess whether the hemorrhage, perforation, pancreatitis and other complications of retrograde cholangiopancreatography (ERCP) happen or not by clinical sympton and blood index 1 day after the ERCP. The blood index includes CRP, amylase,lipase,leukocyte,red blood cell,hemoglobin.Besides,CT will be done if necessary.Finally investigators use statistical method to analyse the incidence of composite events of infection, hemorrhage, perforation, pancreatitis.

    3 and 24 hours after the ERCP

Secondary Outcomes (1)

  • Recurrence rate of bile duct stones

    1 year after the ERCP.

Study Arms (3)

EST

EXPERIMENTAL

EST is an operation using the Erbao electric knife and Three-cavity incision knife to make a large incision to the duodenal nipples,and the incision scope is the nipple mouth uplift length of 4/5. It has been used since 1974. The technique is intuitive and intact. However, EST cut too small to achieve the purpose of treatment and will affect the next step, and if the incision is too large it may be easier to occur gastrointestinal perforation and bleeding.The EST will also damage the anatomy of the Oddi sphincter structure,which causes bacterial reflux to the bile duct, the recurrence of CBD.Some surgeons prefer it because it's postoperative pancreatitis rate is lower and it may be easier to find the lesion position if bleeding or perforation occurs.

Device: Erbao electric knifeDevice: Three-cavity incision knife

EPBD

EXPERIMENTAL

EPBD is an operation using the Columnar expansion balloon to expand duodenal to achieve the purpose of using the basket and other instruments to take stone out. Balloon expansion may retain part of the sphincter not destroyed, and basically retain the normal physiological function of the nipple sphincter.Thus it may reduce the risk of recurrence of stones and bacterial reflux. However,the postoperative pancreatitis rate is high(4.8% -19.5% ), and nipple sphincter tear is uncontrollable in EPBD.If the digestive tract perforation or bleeding occur after EPBD,it is hard to accurately find the lesion position.Some surgeons prefer it for it's lower bleeding and perforation rate.

Device: Columnar expansion balloon

sEST+EPBD

EXPERIMENTAL

sEST+EPBD is an operation combining EST and EPBD. Investigators use the Erbao electric knife and Three-cavity incision knife to make a small incision to the duodenal nipples, and the incision length is less than 5mm while the incision scope is less than the nipple mouth uplift length of 1/2. Then, Investigators match the appropriate Columnar expansion balloon according to the diameter of the common bile duct and gradually expand the duodenal nipples.This method allows the nipple sphincter to be cut in a small range, then the balloon can guide the direction of the nipple sphincter tearing after the expansion , so that the digestive tract bleeding, perforation may be smaller and more controllable. Besides,it may reduce postoperative pancreatitis rate and the recurrence rate of stones.

Device: Erbao electric knifeDevice: Three-cavity incision knifeDevice: Columnar expansion balloon

Interventions

Erbao electric knife is used to cut the Duodenal sphincter

ESTsEST+EPBD

Three-cavity incision knife is used to cut the Duodenal sphincter

ESTsEST+EPBD

Columnar expansion balloon is used to expand the the Duodenal sphincter

EPBDsEST+EPBD

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 20-80 years old
  • CT or MRCP diagnose the patients with Common bile duct stones
  • The diameter of the stone is less than or equal to 1.5cm
  • Patients with the indications for ERCP
  • Patients and their families agree to participate in the trial

You may not qualify if:

  • Stones are too large (\> 1.5cm)
  • A history of gastrointestinal surgery
  • ERCP and EST or EPBD surgery history
  • Patients generally poor, total bilirubin\> 200umol / L or PT time extension\> 3s
  • Patients with mental illness or other serious heart and lung disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhujiang Hospital

Guangzhou, Guangdong, 510282, China

Location

Study Officials

  • Changhui Yu, Doctor

    Zhujiang Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2017

First Posted

January 31, 2018

Study Start

July 20, 2017

Primary Completion

September 1, 2021

Study Completion

September 1, 2021

Last Updated

March 19, 2018

Record last verified: 2017-05

Locations